245 related articles for article (PubMed ID: 17304462)
1. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute.
Hindler JF; Stelling J
Clin Infect Dis; 2007 Mar; 44(6):867-73. PubMed ID: 17304462
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations for the analysis of cumulated data in antimicrobial susceptibility in health institutions].
Comité de Microbiología, Sociedad Chilena de Infectología
Rev Chilena Infectol; 2010 Apr; 27(2):126-32. PubMed ID: 20556314
[TBL] [Abstract][Full Text] [Related]
3. Hospital antibiogram: a necessity.
Joshi S
Indian J Med Microbiol; 2010; 28(4):277-80. PubMed ID: 20966554
[TBL] [Abstract][Full Text] [Related]
4. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
Ernst EJ; Diekema DJ; BootsMiller BJ; Vaughn T; Yankey JW; Flach SD; Ward MM; Franciscus CL; Acosta E; Pfaller MA; Doebbeling BN
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):141-5. PubMed ID: 15183864
[TBL] [Abstract][Full Text] [Related]
5. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.
Pakyz AL
Pharmacotherapy; 2007 Sep; 27(9):1306-12. PubMed ID: 17723084
[TBL] [Abstract][Full Text] [Related]
6. Development of an antibiogram in a long-term care facility.
Phillippe HM; Darling CH; Aikens GB; Wargo KA
Consult Pharm; 2011 Nov; 26(11):829-36. PubMed ID: 22079792
[TBL] [Abstract][Full Text] [Related]
7. Nationwide antibiogram analysis using NCCLS M39-A guidelines.
Zapantis A; Lacy MK; Horvat RT; Grauer D; Barnes BJ; O'Neal B; Couldry R
J Clin Microbiol; 2005 Jun; 43(6):2629-34. PubMed ID: 15956376
[TBL] [Abstract][Full Text] [Related]
8. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs.
Pedersen K; Pedersen K; Jensen H; Finster K; Jensen VF; Heuer OE
J Antimicrob Chemother; 2007 Oct; 60(4):775-81. PubMed ID: 17644533
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
Korten V; Ulusoy S; Zarakolu P; Mete B;
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
[TBL] [Abstract][Full Text] [Related]
11. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.
Jorgensen JH; Hindler JF
Clin Infect Dis; 2007 Jan; 44(2):280-6. PubMed ID: 17173232
[TBL] [Abstract][Full Text] [Related]
12. Blood culture isolates and antimicrobial sensitivities from 427 critically ill neonatal foals.
Russell CM; Axon JE; Blishen A; Begg AP
Aust Vet J; 2008 Jul; 86(7):266-71. PubMed ID: 18616477
[TBL] [Abstract][Full Text] [Related]
13. [Consensus on antimicrobial sensitivity tests in gram-positive cocci. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
Famiglietti A; Quinteros M; Predari SC; Corso A; Lopardo H; Casellas JM; Bantar C; Couto E; Galas M; Goldberg M; Gutkind G; Kovensky Pupko J; Marín M; Nicola F; Pasterán F; Radice M; Soloaga R
Rev Argent Microbiol; 2003; 35(1):29-40. PubMed ID: 12833678
[TBL] [Abstract][Full Text] [Related]
14. Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay.
Kuster SP; Ruef C; Zbinden R; Gottschalk J; Ledergerber B; Neuber L; Weber R
J Antimicrob Chemother; 2008 Dec; 62(6):1451-61. PubMed ID: 18776189
[TBL] [Abstract][Full Text] [Related]
15. Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility. MYSTIC Advisory Board. Meropenem Yearly Susceptibility Test Information Collection.
Jones RN
J Antimicrob Chemother; 2000 Sep; 46 Suppl T2():1-8. PubMed ID: 11065144
[TBL] [Abstract][Full Text] [Related]
16. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
[No Abstract] [Full Text] [Related]
17. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
Jones RN; Kirby JT; Rhomberg PR
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the susceptibility trends to meropenem in a nationwide collection of clinical isolates in Japan: a longitudinal analysis from 2002 to 2006.
Ishii Y; Yamaguchi K;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):346-50. PubMed ID: 18339507
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of antimicrobial resistance.
Maragakis LL; Perencevich EN; Cosgrove SE
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
[TBL] [Abstract][Full Text] [Related]
20. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
